88
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Mercury Toxicity and Systemic Elimination Agents

&
Pages 53-62 | Published online: 13 Jul 2009

References

  • Toxicologica l Profile for Mercury. US Department of Health & Human Services, Agency for Toxic Substance s and Disease Registry. Division of Toxicology/Toxicolog y Informatio n Branch, 1600 Clifton Road NE, E-29, Atlanta, Georgia 3033, USA, March 1999.
  • Richardso n GM. Assessment of mercury exposur e and risks from dental amalgam. Medical Devices Bureau, Environmental Health Directorate, Health Canada, 1995.
  • Stajich GV, Lopez GP, Harry SW et al. Iatrogenic exposur e to mercury after hepatiti s B vaccinatio n in preterm infants. J Pediatr 2000 May;136(5): 679–81.
  • Pless R, Risher JF. Mercury, infant neurodevelopment, and vaccination. J Pediatr 2000 May; 136(5): 571–3.
  • Offit PA. Preventing harm from thimerosa l in vaccines. JAMA 2000 Apr 26; 283(16): 2104.
  • Centers for Disease Control and Prevention. Recommendation s regardin g the use of vaccine s that contain thimerosa l as a preservative. JAMA 1999 Dec 8; 282(22):2114–15.
  • Inouye M, Murakam i U. Placental transfer of methylmercur y and mercuric mercury in mice. Environ Med 1990; 34: 160–72.
  • Kuntz WD, Pitkin RM, Bonstrom AW et al. Maternal and cord blood backgroun d levels. A longitudina l surveillance. Am J Obstet Gynecol 1982; 143: 440–3.
  • Harrison IA. Some electrochemica l features of the in vivo corrosio n of dental amalgams. J Appl Electroche m 1989; 19: 301–10.
  • Marek M. Dissolutio n of mercury vapor in simulated oral environments. Dent Mater 1997 Sep; 13(5): 312–15.
  • World Health Organization. Inorgani c Mercury. Geneva: World Health Organization, Internationa l Programme on Chemical Safety, 1991, Vol. 118.
  • Skare I, Engqvist A. Human exposur e to mercury and silver release d from dental amalgam restorations. Arch Environ Health 1994; 49: 384–94.
  • World Health Organization. Environmenta l Health Criteria. 118, Inorgani c Mercury (Friber I, ed.). Geneva: World Health Organization, 1991.
  • Berry TC, Nicholson J, Torendle K. Almost two centurie s with amalgam. Where are we today? J Am Dent Assoc 1994;120:39 4–395
  • Lorschide r F, Vimy MJ, Summers, AO. Mercury exposur e from “silver” tooth fillings: Emerging evidence question s a traditiona l dental paradigm. FASEB J 1995; 9 504–8.
  • Lorscheider F, Vimy MJ. Evaluation of the safety issue of mercury release from dental fillings. FASEB J 1993; 7: 1432–3.
  • Bjorkman L, Sandborgh-Englun d G, Ekstrand J. Mercury in saliva and feces after removal of amalgam fillings. Toxicol Appl Pharmacol 1997; 144: 156–62.
  • Svare CW, Peterson LC, Reinhardt JW, Boyer DB et.al. The effects of dental amalgams on mercury levels in expired air. J Dent Res 1981; 60: 1668–71.
  • Vimy MJ, Lorscheide r F. Intra-ora l air mercury released from dental amalgam. J Dent Res 1985; 64: 1069–71.
  • Aronsson AM, Lind B, Nylander M, Nordberg M. Dental amalgam and mercury. Biol Metals 1989; 2: 25–30.
  • Hanson M, Pleva J. The dental amalgam issue. A review. J Experenti a 1991; 47: 479–22.
  • Zalups RK. Molecular interaction s with mercury in the kidney. Pharmacol Rev 2000 Mar; 52(1): 113–43.
  • Hahn LJ, Kloiber R, Leininzer RW, Vimy MJ, Lorscheide r FI. Whole-bod y imaging of the distributio n of mercury released from dental fillings into monkey tissues. FASEB J 1990; 4: 3256–60.
  • Zahnaerztl, Knappwost et al. Abgabe von Quecksilberdamp f aus Dentalamalgame n unter Mundbedin- gungen. Welt/Reform 1985; 94, 131–38.
  • Nierenber g DW, Nordgren RE, Chang MB et al. Delayed cerebella r disease and death after accidental exposure to dimethylmercury. N Engl J Med 1998; 338 (23):1672–7.
  • Clarkson TW. Mercury—an element of mystery. N Engl J Med 1990; 323: 1137–9.
  • The toxicologica l profile of mercury. US Department of Health and Human Services (Agency for Toxic Substance s and Disease Registry, Division of Toxicology; 1600 Clifton Road NE E-29, Atlanta, GA 30333), 1994.
  • Eggleston DW, Nylander M. Correlatio n of dental amalgam with mercury in the brain. J Prost Dent 1987; 58: 704–7.
  • Arvidson B. Retrograde axonal transpor t of mercury; Exp Neurol 1987; 98: 198–203.
  • Arvidson B. Inorganic mercury is transporte d from muscular nerve terminals to spinal and brainste m motorneurons. Muscle Nerve 1992; 15: 1089–94.
  • Daundere r M. Handbuch der Amalgamvergifung. Ecomed Verlag, Mu¨ nich, 1996.
  • Clarkson TW, Hursh IB, Sager PR, Sverson TLM. Mercury. In: Clarkson TW, Friberg L, Nordberg CF, Sager PR (eds.). Biologica l Monitorin g of Toxic Metals. New York: Plenum, 1988, 199–246.
  • Klassen CD. Heavy metals and heavy-meta l antagonists. In: Gilman AC, Rall TW, Niew AS, Taylor P (eds.). The Pharmacologica l Basis of Therapeutics. New York: Pergamon Press, 8th edn., 1990, 1598–602.
  • Pendergrass JC, Haley BE, Vimy MJ et al. Mercury vapor inhalatio n inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer disease d brain. Neurotoxicolog y 1997; 18(2): 315–24.
  • Pendergrass JC, Haley BE. Inhibitio n of brain tubulin-guanosin e 59-triphosphat e interaction s by mercury: similarity to observation s in Alzheimer’s disease d brain. Met Ions Biol Syst 1997; 34: 461–78.
  • Hirsch F, Kuhn J, Ventura M, Vial MC, Fournie G, Druet P. Productio n of monoclona l antibodies. J Immunol 1986; 136: 3272–6.
  • Hultman P, Johansson U, Turley Sj, Lindh U, Enestrom S, Pollard KM. Adverse immunologica l effects and autoimmunit y induced by dental amalgam and alloy in mice. FASEB J 1994; 8: 1183–90.
  • Biagazzi M, Pierlguigi E. Autoimmunity and heavy metals. Lupus 1994; 3: 449–53.
  • Nylander M, Frierg I, Lind B. Mercury concentration s in the human brain and kidneys in relation to exposure from dental amalgam fillings. Swed Dent J 1987; 11: 179–87.
  • Dondero F, Lenzi A, Lombardo F, Gandini L. Therapy of immunologic infertility. Acta Eur Fertil1991; 22: 139–45.
  • Rowlands AS, Baird DD, Weinberg CP, Shore DL, Shy CM, Wilcos AJ. The effect of occupationa l exposure to mercury vapor on the fertility of female dental assistants. Occup Environ Med 1994; 51: 28–34.
  • Gerhard I, Monga B, Waldbrenne r A, Runnebau m B. Heavy metals and fertility. J Toxicol Environ Health 1998; 21; 54 (8):593–611.
  • Gerhard I, Frick A, Monga B. Diagnosis of mercury body burden. Clin Lab 1997; 43: 637–47.
  • Duhr E, Pendergrass s C, Kasarskis E, Slevin J Haley B. Mercury induces GTP-tubulin interaction s inrat brain similar to those observe d in Alzheimer’s disease. FASEB J 1991; 5: 456.
  • Hultman P, Johansso n U, Turle SJ et al. Adverse immunologica l effects and autoimmunit y induced by dental amalgam and alloy in mice. FASEB J 1994; 8: 1183–90.
  • Siblered TL, Kienholz E. Evidence that mercury from silver dental fillings may be an etiologica l factor in reduced nerve conductio n velocity in multiple sclerosi s patients. J Orthomol Med 1997; 12(3): 169–72.
  • Barregard L, Lindtedt G, Shutz A et al. Endocrine function in mercury expose d chloralkal i wokers. Occup Environ Med 1994; 51(8): 536–40.
  • Moszczynsk i P, Lisiewica J, Bartus R, et al. Lymphocytes T and NK cells in men occupationall y exposed to mercury vapors. Int J Occup Med Environ Health 1995; 8 (1):49–56.
  • Summers AO, Wireman J, Vimy MI, Lorscheide r FI, Marshall B, Levy SB et al. Mercury released from dental silver fillings provoke s an increase in mercury and antibiotic-resistan t bacteria in oral and intestina l floras of primates. Antimicrob Agents Chemother 1993; 37: 825–34.
  • Escheverria D, Hever N, Martin MD, Naleway CA, Woods JS Bittner AC. Behavioral effects of low level exposur e to mercury among dentists. Neurotoxico l Teratol 1995; 17: 161–8.
  • Ngim CH. Chronic neurobiologica l effects of elemental mercury in dentists. Br J Indust Med 1992; 49: 782–90.
  • Siblerud RL. The relationshi p between mercury from dental amalgam and mental health. Am J Psychotherap y 1989; 18: 575–87.
  • Powell JE, Edwards A, Edwards M et al. Changes in the incidenc e of childhoo d autism and other autistic spectru m disorder s in preschool children from two areas of the West Midlands, UK. Dev Med Child Neurol 2000 Sep; 42(9): 624–8.
  • Tanguay PE. Pervasive developmenta l disorders: a 10-year review. J Am Acad Child Adolesc Psychiatry 2000 Sep; 39(9): 1079–95.
  • Rice D, Barone S Jr. Critical periods of vulnerabilit y for the developin g nervous system: evidence from humans and animal models. Environ Health Perspect 2000 Jun; 108 Suppl 3: 511–33.
  • Frustaci A, Magnavita N, Chimenti C et al. Marked elevatio n of myocardia l trace elements in idiopathi c dilated cardiomyopathy. J Am Coll Cardiolog y 1999; 33: 1578–83.
  • Chang YC, Yeh C, Wang JD. Subclinica l neurotoxicit y of mercury vapor revealed by a multimodality evoked potentia l study of chloralkal i workers. Amer J Ind Med 1995; 27(2): 271–9.
  • Yang Y-J, Huang C-C, Shih T-S et al. Chronic elemental mercury intoxication: clinical and field studies in lampsocke d manufacturers. Occup Environ Med 1994; 57(1): 245–7.
  • Bluhm RE, Bobbitt RG, Wlech LW et al. Elemental mercury vapour toxicity, treatment and prognosi s after acute intensive exposur e in chloraklal i plant workers. Part 1I. History, neuropsychologica l findings and chelato r effects. Hum Exp Toxicol 1992 11(3):201–10.
  • Clarkson TW. Mercury. J Am Coll Toxicol 1989; 8(7): 1291–6.
  • Eley BM. The future of dental amalgam: a review of the literature. Part 2: Mercury exposur e in dental practice. Br Dent J 1997; 182 (8):293–7.
  • Petrunkin VE. Synthesis and propertie s of demercapt o derivative s of alkylsulfoni c acids. Toksikol Mosc 1958; 21: 53–9.
  • Torres-Alani s O, Garza-Ocana s L, Pineyro-Lopez A. Evaluatio n of urinary mercury excretion after administratio n of 2,3-dimercapto-1-propan e sulfoni c acid to occupationall y expose d men. J Toxicol Clin Toxicol 1995; 33(6): 717–20.
  • Aaseth J, Jacobsen D, Andersen O, Wickstrom E. Treatment of mercury and lead poisoning s with dimercaptosuccini c acid and sodium dimercaptopropanesulfonate. Analyst 1995; 120(3): 853–4.
  • Aposhian HV, Maiorino RM, Rivera M et al. Human studies with the chelating agents, DMPS and DMSA. J Toxicol Clin Toxicol 1992; 30(4): 505–28.
  • Aposhian HV, Aposhia MM. Meso-2,3 dimercaptosuccini c acid: chemical, pharmacologica l and toxicologica l propertie s of an orally effective metal chelating agent. Annu Rev Toxicol 1990; 30: 279–306.
  • Lorscheider FL, Vimy MJ. Evaluation of the safety issue of mercury release from dental fillings. FASEB J 1993; 7: 1432–1433.
  • Aposhian VK. Mobilizatio n of mercury and arsenic in humans by sodium 2,3 dimercapto-1-propan e Sulfonate (DMPS). Environ Health Perspect 1998; 106(Supp l 4): 1017–25.
  • Crinnion WJ. Environmenta l medicine, part three: long-ter m effects of chronic low-dose mercury exposure Altern Med Rev 2000 Jun; 5 (3):209–23.
  • Schiele R, Schaller KH, Welte D. Mobilization of mercury reserve s in the organism by means of DMPS. Occup Med Soc Med Prevent Med 1989; 24: 249–51.
  • Kidd RF. Results of dental amalgam removal and mercury detoxification using DMPS and neural therapy. Altern Ther Health Med 2000 Jul; 6(4): 49–55.
  • Belles M, Sanchez DJ, Gomez M, Domingo JL, Jones MM, Singh PK. Assessment of the protective activity of monisoamyl meso-2,3-dimercaptosuccinat e against methylmercury-induce d maternal and embryo/fetal toxicity in mice. Toxicology 1996; 106(1–3): 93–7.
  • Kostial K, Restek-Samarzij a N, Blanusa M, Piasek M, Prester L, Jones MM, Singh PK. Racemic-2,3- dimercaptosuccini c acid for inorgani c mercury mobilizatio n in rats. J Appl Toxicol 1997; 17 (1):71–4.
  • Gerhard I, Runnebaum B. Schadstoff e und Fertiliatatsstorunge n Schwermetalle und Mineralstoffe. Geburtshilf e Frauenheillk d 1992; 52: 383–96, 509–15.
  • Baum CR. Treatment of mercury intoxication. Curr Opin Pediatr 1999 Jun; 11(3): 265–8.
  • Vamnes JS, Eide R, Isrenn R, Hol PJ et al. Diagnostic value of a chelating agent in patients with symptoms allegedly caused by amalgam fillings. J Dent Res 2000 Mar; 79(3): 868–74.
  • Sallsten G, Barregard L, Schutz A. Clearance half life of mercury in urine after the cessatio n of long term occupationa l exposure: influence of a chelatin g agent (DMPS) on excretion of mercury in urine. Occup Environ Med 1994; 51(5): 337–42.
  • Afonne OJ, Orisakwe OE, Ndubuka GI et al. Zinc protectio n of mercury-induce d hepatic toxicity in mice. Biol Pharm Bull 2000 Mar; 23(3): 305–8.
  • Aposhian HV, Maiorino RM, Gonzalez-Ramire z D et al. Mobilization of heavy metals by newer, therapeuticall y useful chelating agents. Toxicolog y 1995; 31; 97(1–3): 23–38.
  • Gonzalez-Ramire z D, Maiorino RM, Zuniga-Charle s M et al. Sodium 2,3-dimercaptopropane-1-sul - fonate challenge test for mercury in humans: II. Urinary mercury, porphyrin s and neurobehaviora l changes of dental workers in Monterrey, Mexico. J Pharmacol Exp Ther 1995; 272(1): 264–74.
  • Kostial K, Restek-Samarzij a N, Blanusa M, Piasek M, Jones MM, Singh PK. Combined oral treatment with racemic and meso-2,3-dimercaptosuccini c acid for removal of mercury in rats. Pharmacol Toxicol 1997; 81(5):242–4.
  • Miller AL. Dimercaptosuccini c acid (DMSA), a non-toxic, water-solubl e treatment for heavy metal toxicity. Altern Med Rev 1998; 3(3): 199–207.
  • Hurlbut KM, Maiorino RM, Mayersoh n M, Dart RC, Bruce DC, Aposhian HV. Determinatio n and metabolis m of dithiol chelatin g agents. XVI: Pharmacokinetic s of 2,3-dimercapto-1-propanesulfonat e after intravenou s administratio n to human volunteers. J Pharmacol Exp Ther 1994; 268 (2):662–8.
  • Zheng W, Maiorino RM, Brendel K, Aposhia HV. Determinatio n and metabolism of dithiol chelating agents. Fundam Appl Toxicol 1990;1 4: 598–607.
  • Aposhian HV. Mobilizatio n of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propan e sulfonate. Environ Health Perspect 1998; 106 Suppl 4: 1017–25.
  • Research data presented at the annual meeting of the Australasia n Society of Oral Medicine and Toxicolog y in Sydney, Australia, September 1998.
  • Xue HB, Stumm W, Sigg L. The binding of heavy metals to algal surfaces. Water Res 1988; 22: 917.
  • Ahner AB, Kong KS, Morell MM. Phytochelati n productio n in marine algae: an interspecie scomparison. Limnol Oceanograp h 1995; 40: 649–57.
  • Carr HP et al. Characterizatio n of the cadmium-bindin g capacity of Chlorella vulgaris. Bull Environ Contam Toxicol 1998; 60 (3):433–40.
  • Tsezos M. Biosorptio n of radioactiv e species, in: Biosorption of Heavy Metals. B.Volesky B (ed.), Boca Raton, FL: CRC Press, 1990, 45–50.
  • Kraft M. Bindungsverhalte n von Arsen, Cadmium, Chrom, Quecksilber, Nickel und Blei an schw- erverdaulich e Lebensmittel und Lebensmittelkomponente n in kuenstliche m Magen-Darm-Saft. PhD Thesis. Institut fuer Hygiene, Sozial-un d umweltmedizin der Ruhr-Universitae t Bochum, Germany, 1998.
  • Klinghard t D. Amalgam/mercury detox as a treatment for chronic viral, bacterial, and fungal illnesses. Explore! 1997; 8(3): 54–61.
  • Muzzarell i R, Tubertini O. Chitin and chitosan on chromatographi c support s and adsorbent s for collectio n of metal ions from organic and aqueou s solutions and sea water, Talanta 1969; 16: 1571.
  • Subramania n Y, Yoshinar T. Studies on the Formation of Chitin-Meta l Complexes, Report No. 27, Marine Sciences Center, McGill University, Montreal, 1974.
  • Park J W, Park M O. Mechanis m of metal ion binding to chitosa n in solution, cooperativ e inter- and intramolecula r chelations. Bull Korean Chem Soc 1984; 5(3): 108.
  • Omura Y, Beckman SL. Role of mercury (Hg) in resistant infection s and effectiv e treatment of Chlamydia trachomati s and Herpes family viral infections (and potentia l treatment for cancer) by removing localized Hg deposit s with Chinese parsley and deliverin g effectiv e antibiotic s using various drug uptake enhancemen t methods. Acupunct Electrothe r Res 1995; 20(3–4): 195–229.
  • Omura Y, Shimotsuura Y, Fukuoka A, Fukuoka H, Nomoto T. Significant mercury deposits in internal organs following the removal of dental amalgam, and developmen t of pre-cance r on the gingiva and the sides of the tongue and their represente d organs as a result of inadverten t exposure to strong curing light (used to solidif y synthetic dental filling material) and effectiv e treatment: a clinical case report, along with organ representatio n areas for each tooth. Acupunct Electrothe r Res 1996; 21(2): 133–60.
  • Ewan KB, Pamphlett R. Increase d inorgani c mercury in spinal motor neuron s following chelating agents. Neurotoxicolog y 1996; 17(2): 343–9.
  • Cha CW. A study on the effect of garlic to the heavy metal poisoning of rat. J Korean Med Sci 1987; 2(4): 213–24.
  • Lee JH, Kang HS, Roh, J. Protective effects of garlic juice against embryotoxicit y of methylmercuri c chloride administere d to pregnant Fischer 344 rats. J Yonsei Med J 1999 Oct; 40(5): 483–9.
  • Jacob S, Lawrence RM, Zucker M. The Miracle of MSM: The Natural Solution for Pain. New York: Penguin Putnam, 1999.
  • Stjernberg L, Berglund J. Garlic as an insect repellent. JAMA. 2000 Aug 16; 284(7): 831.
  • Fleischauer AT, Poole C, Arab L. Garlic consumptio n and cancer prevention: meta-analyse s of colorecta l and stomach cancers. Am J Clin Nutr 2000 Oct; 72(4): 1047–52.
  • Morelli V, Zoorob RJ. Alternativ e therapies: Part II. Congestiv e heart failure and hypercholes - terolemia. Am Fam Physician 2000 Sep 15; 62(6): 1325–30.
  • Chang LW, Gilbert M, Sprecher J. Modification of methylmercur y neurotoxicit y by vitamin E. Environ.Res 1978; 17: 356–66.
  • Yoneda S, Suzuki KT. Detoxification of mercury by selenium by binding of equimolar Hg-Se complex to a specific plasma protein. Toxicol Appl Pharmacol 1997; 143(2): 274–80.
  • Akesson I, Ingrid B. Status of mercury and selenium in dental personnel: Impact of amalgam work and own fillings. Arch Environ Health 1991; 46(2): 103–9.
  • Johansso n E. Selenium and its protection against the effects of mercury and silver. J Trace Elem 1991; 5: 273–4.
  • Gailer J. George GN, Pickering IJ et al. Structural basis of the antagonis m between inorganic mercury and selenium in mammals. Chem Res Toxicol 2000 Nov 20; 13(11): 1135–42.
  • Hultberg B, Andersson A, Isaksso n A. Thiol and redox reactive agents exert differen t effects on glutathion e metabolism in HeLa cell cultures. Clin Chim Acta 1999 May; 283(1–2): 21–32.
  • Westphal GA, Schnuch A, Schulz TG et al. Homozygous gene deletions of the glutathion e S-trans- ferases M1 and T1 are associated with thimerosa l sensitization. Int Arch Occup Environ Health 2000 Aug; 73(6):384–8.
  • Schurz(1) F, Sabater-Vila r M, Fink-Gremmels J. Mutagenicit y of mercury chloride and mechanisms of cellular defence: the role of metal-bindin g proteins. Mutagenesis 2000 Nov; 15(6): 525–30.
  • Dringen R, Gutterer JM, Hirrlinger J. Glutathion e metabolism in brain metabolic interaction between astrocyte s and neurons in the defense against reactive oxygen species. Eur J Biochem 2000 Aug; 267(16): 4912–16.
  • Hayes JD, McLellan LI. Glutathione and glutathione-dependen t enzymes represen t a co-ordinatel y regulated defence against oxidativ e stress. Free Radic Res 1999 Oct; 31(4): 273–300.
  • Anuradha B, Varalakshm i P. Protective role of DL-alpha-lipoi c acid against mercury-induce d neural lipid peroxidation. Pharmacol Res 1999 Jan; 39(1): 67–80.
  • Ballatori N, Lieberman MW, Wang W. N-acetylcystein e as an antidot e in methylmercur y poisoning. Environ Health Perspect 1998 May; 106(5): 267–71.
  • Dirks M, Marvin J. Mercury excretion and intravenou s ascorbic acid. Arch Environ Health 1994; 49(1): 49–52.
  • Hill CH. Interaction s of vitamin C with lead and mercury. Ann N Y Acad Sci 1980; 355: 262–6.
  • Yamini B, Sleight SD. Effects of ascorbi c acid deficiency on methyl mercury dicyandiamid e toxicosisin guinea pigs. J Environ Pathol Toxicol Oncol 1984 Jul; 5(4–5): 139–50.
  • Zorn NE, Smith JT. A relationshi p between vitamin B12, folic acid, ascorbi c acid, and mercury uptake and methylation. Life Sci 1990; 47(2): 167–73.
  • Sorg O, Schilter B, Honegger P et. al. Increase d vulnerabilit y of neurones and glial cells to lowconcentration s of methylmercur y in a prooxidan t situation. Acta Neuropatho l (Berl) 1998 Dec; 96(6): 621–7.
  • Iyenga r GV, Nair PP. Global outlook on nutritio n and the environment: meeting the challenge s of the next millennium. Sci Total Environ 2000 Apr 17; 249(1–3): 331–46.
  • Chen WY, Abatangelo G. Functions of hyalurona n in wound repair. Wound Repair Regen 1999; 7(2): 79–89.
  • Delpech B, Girard N, Bertrand P, Courel MN, Chauzy C, Delpech, A. Hyaluronan: fundamental principle s and application s in cancer. J Intern Med 1997; 242(1): 41–8.
  • Sutherland IW. Novel and establishe d application s of microbial polysaccharides. Trends Biotechnol 1998; 16(1): 41–6.
  • Knudson CB, Nofal GA, Pamintuan L, Aguiar DJ. The chondrocyt e pericellula r matrix: a model for hyaluronan-mediate d cell-matri x interactions. Biochem Soc Trans 1999; 27(2): 142–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.